Fish oil alleviates liver injury induced by intestinal ischemia/reperfusion via AMPK/SIRT-1/autophagy pathway

World J Gastroenterol. 2018 Feb 21;24(7):833-843. doi: 10.3748/wjg.v24.i7.833.

Abstract

Aim: To evaluate whether fish oil (FO) can protect liver injury induced by intestinal ischemia/reperfusion (I/R) via the AMPK/SIRT-1/autophagy pathway.

Methods: Ischemia in Wistar rats was induced by superior mesenteric artery occlusion for 60 min and reperfusion for 240 min. One milliliter per day of FO emulsion or normal saline was administered by intraperitoneal injection for 5 consecutive days to each animal. Animals were sacrificed at the end of reperfusion. Blood and tissue samples were collected for analyses. AMPK, SIRT-1, and Beclin-1 expression was determined in lipopolysaccharide (LPS)-stimulated HepG2 cells with or without FO emulsion treatment.

Results: Intestinal I/R induced significant liver morphological changes and increased serum alanine aminotransferase and aspartate aminotransferase levels. Expression of p-AMPK/AMPK, SIRT-1, and autophagy markers was decreased whereas tumor necrosis factor-α (TNF-α) and malonaldehyde (MDA) were increased. FO emulsion blocked the changes of the above indicators effectively. Besides, in LPS-stimulated HepG2 cells, small interfering RNA (siRNA) targeting AMPK impaired the FO induced increase of p-AMPK, SIRT-1, and Beclin-1 and decrease of TNF-α and MDA. SIRT-1 siRNA impaired the increase of SIRT-1 and Beclin-1 and the decrease of TNF-α and MDA.

Conclusion: Our study indicates that FO may protect the liver against intestinal I/R induced injury through the AMPK/SIRT-1/autophagy pathway.

Keywords: AMPK/SIRT1/autophagy; Fish oil; Intestinal ischemia/reperfusion; Liver injury.

MeSH terms

  • AMP-Activated Protein Kinases / genetics
  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Autophagy / drug effects*
  • Beclin-1 / metabolism
  • Biomarkers / metabolism
  • Fish Oils / pharmacology*
  • Fish Oils / therapeutic use
  • Hep G2 Cells
  • Humans
  • Lipopolysaccharides / pharmacology
  • Liver / blood supply
  • Liver / drug effects
  • Liver / pathology
  • Liver Diseases / drug therapy*
  • Liver Diseases / etiology
  • Liver Diseases / pathology
  • Male
  • Mesenteric Artery, Superior
  • Mesenteric Ischemia / complications
  • RNA, Small Interfering / metabolism
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / complications
  • Signal Transduction / drug effects*
  • Sirtuin 1 / genetics
  • Sirtuin 1 / metabolism

Substances

  • BECN1 protein, human
  • Beclin-1
  • Biomarkers
  • Fish Oils
  • Lipopolysaccharides
  • RNA, Small Interfering
  • AMP-Activated Protein Kinases
  • SIRT1 protein, human
  • Sirtuin 1